Introduction
============

Meat quality depends on various sensory and chemical parameters, including color, tenderness, and the content of flavoring substances \[[@B1]\]. Fatty acid (FA) composition is one of the most important parameters affecting meat quality. The proportion of saturated, monounsaturated, and polyunsaturated FAs in the diet is reported to have important effects on human health. For instance, high intake of saturated FAs can elevate plasma cholesterol, which can have harmful cardiovascular effects \[[@B2]\]. Further, foods rich in monounsaturated FAs (MUFAs) may decrease platelet aggregation \[[@B3]\], increase bleeding time \[[@B4]\], and increase fibrinolysis \[[@B5]\]; thereby preventing thrombogenesis.

The FA composition of cells is determined by phospholipid metabolism \[[@B6],[@B7]\], FA synthesis \[[@B8]\], and FA transport \[[@B9]-[@B13]\]. Diacylglycerol acyltransferase (DGAT1 and DGAT2) catalyzes the final step in triacylglyceride (TAG) formation through the acylation of diacylglycerol (DAG) \[[@B14],[@B15]\]. DGAT1 plays an important role in incorporating oleoyl-CoA into TAG \[[@B15],[@B16]\]. In COS-7 cells, DGAT2 overexpression has been reported to significantly increase lipid accumulation \[[@B17]\]. In contrast, lipid storage in 3T3-L1 adipocytes was markedly decreased by DGAT2 knockdown \[[@B18]\]. The effect of DGAT2 overexpression on the FA composition of cells is unknown.

This study investigated the effect of DGAT2 overexpression on the FA composition of 3T3-L1 preadipocytes. mRNA and protein expression of adipogenic genes in cells overexpressing DGAT2 was also investigated. Our results revealed a crucial role of DGAT2 in the regulation of FA composition and adipogenic gene expression.

Methods
=======

Generation of 3T3-L1 preadipocytes overexpressing DGAT2
-------------------------------------------------------

The open reading frame region of DGAT2 was subcloned into pcDNA3.1(+) to produce pcDNA3.1(+)-DGAT2, which was then linearized and transfected into 3T3-L1 cells (CL-173, ATCC, USA). Cells transfected with pcDNA3.1(+)-DGAT2 and pcDNA3.1(+) were treated with G418 ( 350 μg/mL) for 14 d until all non-transfected cells died. The selected transfected cells were then cultured in growth medium or differentiation medium supplemented with G418 (150 μg/mL) for further analysis.

Cell culture
------------

3T3-L1 preadipocytes were cultured and induced to differentiate as previously described \[[@B19]\]. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 containing 10% fetal bovine serum (FBS, Life Technologies, Grand Island, NY, USA). After reaching confluence, the cells were induced to differentiate by incubation in DMEM/F12 supplemented with 10% FBS, 0.174 μmol/L insulin, 0.5 mmol/L methylisobutylxanthine, and 1 μmol/L dexamethasone (Sigma- Aldrich, St. Louis, MO, USA). Two days after the initiation of differentiation, dexamethasone and methylisobutylxanthine were withdrawn from the medium. The differentiated 3T3-L1 cells were incubated with three differential medium until the cells matured (12 d): DMEM/F12, 10% charcoal-stripped FBS, and 0.174 μmol/L insulin (DM) (Life Technologies, Grand Island, NY, USA), DM supplemented with unlabeled FA (FA-DM), or DM supplemented with one of the stable isotope-labeled FA mixtures (FAM-DM). FA-DM contained 10 μmol/L C~16~-palmic acid, C~16~-palmitoleic acid, C~18~-stearic acid, C~18~-oleic acid, C~18~-linoleic acid, and C~20~-arachidic acid (Sigma-Aldrich, St. Louis, MO, USA). IFA-DM contained 10 μmol/L ^13^C~16~-palmic acid, ^13^C~18~-stearic acid, ^13^C~18~-oleic acid, (Cambridge Isotope Laboratories, Tewksbury, MA, USA) C~16~-palmitoleic acid, C~18~-linoleic acid, and C~20~-arachidic acid. All FA mixtures were pre-complexed with 60 μmol/L FA-free bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO, USA).

Triglyceride analysis and Oil Red O staining
--------------------------------------------

The cells were washed twice with Ca^2+^- and Mg^2+^-free PBS and lysed using 150 μL of RIPA lysis buffer (50 mmol/L Tris, 150 mmol/L NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mmol/L EDTA, and 1 mmol/L phenylmethylsulfonyl fluoride). The TAG and total protein content of the cells in each well were determined from cell lysates using commercial kits (Biosino Bio-Technology and Science Inc., Beijing, China) on a microplate reader (Thermo Labsystems MK3, Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer's protocol. The TAG content of cells in each well was then normalized to the total protein. Mature adipocytes were rinsed twice with Ca^2+^- and Mg^2+^-free PBS and then fixed in 4% paraformaldehyde in PBS (w/v) for 30 min at room temperature to facilitate Oil Red O staining. A stock solution of 0.35% Oil Red O (Amresco, Inc., Solon, OH, USA) in isopropanol (w/v) was diluted in water (6:4, v/v) and added to the fixed cells for 1 h at room temperature. The cells were then washed with water and photographed.

Analysis of cellular FA composition
-----------------------------------

Cellular lipids were extracted according to a previously described procedure \[[@B20]\], converted to FA methyl esters using BF~3~ and methanolic potassium hydroxide \[[@B21]\], and analyzed using gas chromatography (GC; model MSD-6890; Agilent, USA) equipped with an automatic injector. Aliquots of 1 μL were injected into the capillary column (30 m × 0.32 mm × 0.25 μm; DB-5 MS; Agilent) with cyanopropyl methyl silicone as the stationary phase. The column oven temperature was programmed to hold at 130°C for 1 min, increase from 130°C to 200°C at 5°C/min, and then hold at 200°C for 5 min. Helium was used as the carrier gas at a flow rate of 1 mL/min. The proportions of individual FAs were determined by measuring the peak area using ChemStation software.

Stable isotope-labeled FA profile
---------------------------------

Cellular lipids were extracted and converted to FA methyl esters, which were resolved by GC using a chromatograph (Model 6890, Agilent, USA) equipped with a 30 m × 0.32 mm × 0.25 μm DB-5 MS capillary column (Agilent, USA) and burned to generate CO~2~ and to detect the molecular ions of masses 44, 45, and 46 using isotope ratio mass spectrometry (IR-MS) (GV Instruments, UK). A mixed nominal sample (C~14~-myristic acid, C~30~-FA, C~21~-diolefine, C~26~-diolefine, and C~36~-diolefine; University of Illinois, USA) was used with a standardized isotope value of CO~2~ in the cylinder. The carbon isotope value of each FA was calculated using the formula δ = \[(R~s~/R~R~) − 1\] × 1,000, where δ and R~s/~R~R~ represent the carbon isotope and ^13^C/^12^C values, respectively, of an international nominal sample (Pee Dee Belemnite, South Carolina, USA). The data are relative to control cells transfected with pcDNA3.1(+).

Quantitative PCR
----------------

Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After treatment with DNase I (Takara Bio Inc., Shiga, Japan), total RNA (2 μg) was reverse-transcribed to cDNA in a final volume of 20 μL using M-MLV Reverse Transcriptase (Promega, Madison, WI, USA) and oligo-dT18 random primers according to the manufacturer's instructions. β-actin was used as a standard for gene expression. All primers for the selected genes were designed by Primer Premier 5 (Table  [1](#T1){ref-type="table"}). SYBR Green real-time PCR Master Mix reagents (Toyobo Co., Ltd., Osaka, Japan), cDNA, ddH~2~O, the sense and antisense primers (200 nmol/L for each gene) were used for quantitative PCR, which was performed using an Mx3005p instrument (Stratagene, La Jolla, CA, USA). The thermal cycling conditions were as follows: 95°C for 1 min, followed by 40 cycles of denaturation at 95°C for 15 s, annealing at different temperature for 15 s, and extension at 72°C for 40 s. Melting curve and sequence analyses were performed for each product to confirm the specific amplification. mRNA expression levels in cells overexpressing DGAT2 are presented as a ratio of those in control cells transfected with pcDNA3.1(+).

###### 

Primers used in RT-PCR analysis

  **Gene**                     **GenBank access no.**   **Sequence (5'→3')**          **Product, bp**
  ---------------------------- ------------------------ ----------------------------- -----------------
  HSL                          U08188.1                 F: AGTGCCTATTCAGGGACAGA       184
  R: TGGGCGATGTGGTCTTTT                                                               
  ACACA                        AY451393                 F: GACAGAGGAAGATGGCGTCC       172
  R: TACAACTTCTGCTCGCTGGG                                                             
  a-FABP                       NM_024406.2              F: GCTCATAGCACCCTCCTG         93
  R: TCCAGGTTCCCACAAAGG                                                               
  LPL                          NM_008509.2              F: ACTGCCACTTCAACCACACC       211
  R: GCCACATCATTTCCCACC                                                               
  ATGL                         NM_025802.3              F: GACCTGATGACCACCCTTTC       169
  R: GGCTACCCGTCTGCTCTTT                                                              
  DGAT2                        NM_001160080.1           F: GGCTCAATAGGTCCAAGGTA       96
  R: GGGCGTGTTCCAGTCAAA                                                               
  SCD1                         NM_009127.4              F: GCTCTACACCTGCCTCTTC        103
  R: CCGTGCCTTGTAAGTTCTG                                                              
  β-actin                      NM_007393.3              F: TAAGGCCAACCGTGAAAAGATGAC   422
  R: ACCGCTCGTTGCCAATAGTGATG                                                          
  PPARγ                        NM_001127330.1           F: TCAAGGGTGCCAGTTTCGC        232
  R: GGGCTTCCGCAGGCTTTT                                                               
  FASN                         NM_007988.3              F: CCAAGACTGACTCGGCTACT       280
  R: GCCAGGTTCGGAATGCTAT                                                              
  FAT/CD36                     NM_001159556.1           F: CTGTGGGCTCATTGCTGG         214
                                                        R: CGCCACGTCATCTGGGTTT         

Immunoblot analysis
-------------------

The cells were lysed in RIPA lysis buffer. Homogenates were centrifuged at 12,000 rpm for 5 min at 4°C, and the protein concentration in the supernatants was determined using a BCA protein assay reagent kit (Pierce, Rockford, IL). Protein samples, subjected to a 20% SDS (Beyotime, Shanghai, China), were degenerated for 10 min at 99°C. A total of 30 μg protein were resolved by sodium dodecyl sulfate (SDS)-poly-acrylamide gel electrophoresis (30% acrylamide, 1.5 mol/L Tris (pH8.8), 10% SDS, 10% ammonium persulfate, TEMED; 10% SDS-PAGE) and separated by electrophoresis at 110 V for 75 min using Tris-glycine running buffer (0.025 mol/L Tris base, 0.192 mol/L glycine, and 0.1% SDS, pH 8.3). Proteins then were subsequently electrotransferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA) using transfer buffer containing 25 mmol/L Tris base, 192 mmol/L glycine, and 10% methanol at pH 8.1-8.3. The membranes were blocked with 5% nonfat milk in PBS for 1 h at room temperature. The primary antibodies \[goat anti-LPL, rabbit anti-ATGL, rabbit anti-ACACA, goat anti-SCD1, rabbit anti-CD36 (Santa Cruz Biotechnology Inc., Dallas, Texas, USA); rabbit anti-β-actin (Cell Signaling, Danvers, MA, USA); goat anti-DGAT2, mouse anti-FASN (Lifespan, Providence, RI, USA)\] were incubated at 4°C overnight, followed by incubation with the appropriate secondary antibody (1:1,000, Bioss, Beijing, China) for 1 h at room temperature. Protein expression was measured using a FluorChem M Fluorescent Imaging System (ProteinSimple, Santa Clara, CA, USA) and normalized to β-actin expression.

Statistical analysis
--------------------

The data are presented as the mean ± SEM. An independent t-test was used for statistical analysis of the differences between the means, and the cut-off point for significance was set at *P* \< 0.05.

Results
=======

Lipid accumulation in 3T3-L1 adipocytes overexpressing DGAT2
------------------------------------------------------------

3T3-L1 cells transfected with pcDNA3.1(+)-DGAT2 had 63-fold higher DGAT2 mRNA expression than control cells transfected with empty vector (*P* \< 0.01) (Figure  [1](#F1){ref-type="fig"}). Oil Red O staining and TAG content analysis similarly demonstrated that lipid accumulation was much higher in 3T3-L1 adipocytes overexpressing DGAT2 (Figure  [2](#F2){ref-type="fig"}).

![**DGAT2 mRNA expression in 3T3-L1 adipocytes.** DGAT2 mRNA expression was detected by RT-PCR in 3T3-L1 adipocytes after 12 d of differentiation. Cells transfected with the empty pcDNA3.1(+) vectors were used as control cells. Results are presented as the mean ± SEM of six independent cell preparations. \*\**P* \< 0.01.](2049-1891-5-29-1){#F1}

![**Effect of DGAT2 overexpression on lipid accumulation.** The cells were incubated with FA-DM (DM containing 10 μmol/L C~16~-palmic acid, C~16~- palmitoleic acid, C~18~-stearic acid, C~18~-oleic acid, C~18~-linoleic acid, and C~20~-arachidic acid bound to 60 μmol/L FA-free BSA) for 12 d of differentiation and collected for Oil Red O staining **(A)** and TAG content determination **(B)**. Results are presented as the mean ± SEM of six independent cell preparations and are shown as μmol/g of cellular protein. \*\**P* \< 0.01.](2049-1891-5-29-2){#F2}

FA composition in 3T3-L1 adipocytes overexpressing DGAT2 cultured with DM
-------------------------------------------------------------------------

After 12 d of induction in DM, the proportion of palmitoleic acid (C16:1) and oleic acid (C18:1) was significantly higher in 3T3-L1 adipocytes overexpressing DGAT2 than in control cells (*P* \< 0.05) (Table  [2](#T2){ref-type="table"}). The proportion of palmitic acid (C16:0) and stearic acid (C18:0) decreased with DGAT2 overexpression, but the difference was not significant (*P* \> 0.05) (Table  [2](#T2){ref-type="table"}).

###### 

FA composition of 3T3-L1 adipocytes overexpressing DGAT2 cultured with DM

  **Fatty acids**            **Control**    **DGAT2**          ***P*value**
  -------------------------- -------------- ------------------ --------------
  Palmitoleic acid (C16:1)   2.17 ± 0.52    4.20 ± 0.27^\*^    *P* \< 0.05
  Palmitic acid (C16:0)      48.03 ± 2.90   41.76 ± 2.10       *P* \> 0.05
  Linoleic acid (C18:2)      3.17 ± 0.35    2.94 ± 0.13        *P* \> 0.05
  Oleic acid (C18:1)         18.43 ± 0.13   21.87 ± 0.96^\*^   *P* \< 0.05
  Stearic acid (C18:0)       20.79 ± 1.45   19.97 ± 0.54       *P* \> 0.05
  Arachidonic acid (C20:4)   7.40 ± 0.75    9.26 ± 0.83        *P* \> 0.05

After 12 d of differentiation, cells were collected for FA analysis. Cells were then subjected to transesterification and injected into a GC. The results are expressed as the percent of the total FA content (100%). The data are presented as the mean ± SEM of six independent wells.

\**P* \< 0.05.

FA composition in 3T3-L1 adipocytes overexpressing DGAT2 cultured with FA-DM
----------------------------------------------------------------------------

When cells were cultured with FA-DM for 12 d, the proportion of palmitoleic acid (C16:1; *P* \< 0.05), oleic acid (C18:1; *P* \< 0.01), and linoleic acid (C18:2; *P* \< 0.01) was significantly higher in 3T3-L1 adipocytes overexpressing DGAT2 than in control cells (Table  [3](#T3){ref-type="table"}). The reverse was true for stearic acid (C18:0) and arachidonic acid (C20:4) (*P* \< 0.01; Table  [3](#T3){ref-type="table"}). When the cells were incubated in FA-DM for 30 min, the proportion of palmitoleic acid (C16:1) was slightly elevated in cells overexpressing DGAT2 (*P* \< 0.05) (Table  [3](#T3){ref-type="table"}).

###### 

FA composition of 3T3-L1 adipocytes overexpressing DGAT2 cultured with FA-DM

  **Fatty acids**              **30 min**       **12 d**                       
  -------------------------- -------------- ----------------- ---------------- --------------------
  Myristic acid (C14:0)       2.70 ± 0.15      2.62 ± 0.49      2.84 ± 0.42        2.42 ± 0.29
  Palmitoleic acid (C16:1)    2.67 ± 0.15    3.86 ± 0.33^\*^    2.61 ± 0.17      3.54 ± 0.33^\*^
  Palmitic acid (C16:0)       39.11 ± 4.55    33.61 ± 2.104    31.17 ± 1.1003      29.23 ± 1.34
  Linoleic acid (C18:2)       5.14 ± 0.38      6.63 ± 1.74      8.44 ± 0.29     11.38 ± 0.41^\*\*^
  Oleic acid (C18:1)          14.18 ± 1.19    12.31 ± 1.07      8.66 ± 0.32     16.47 ± 0.52^\*\*^
  Stearic acid (C18:0)        22.95 ± 2.33    26.45 ± 0.99      26.76 ± 0.42    22.54 ± 0.90^\*\*^
  Arachidonic acid (C20:4)    12.29 ± 1.88    13.56 ± 1.99      15.65 ± 0.46    9.86 ± 1.10^\*\*^
  Arachidic acid (C20:0)      0.96 ± 0.04      0.96 ± 0.15      4.73 ± 0.21        4.55 ± 0.36

3T3-L1 adipocytes were incubated with FA-DM (10 μmol/L C~16~-palmic acid, C~16~-palmitoleic acid, C~18~-stearic acid, C~18~-oleic acid, C~18~-linoleic acid, and C~20~-arachidic acid bound to 60 μmol/L FA-free BSA) for 30 min or 12 d. Cells were then subjected to transesterification and injected into a GC for FA analysis. The results are expressed as the percent of the total FA content (100%). The data are presented as the mean ± SEM of six independent wells.

\**P* \< 0.05; \*\**P* \< 0.01.

FA composition in 3T3-L1 adipocytes overexpressing DGAT2 cultured with IFA-DM
-----------------------------------------------------------------------------

When cells were cultured with IFA-DM for 12 d, the proportion of ^13^C FAs were the same in 3T3-L1 adipocytes overexpressing DGAT2 and control cells (*P* \> 0.05) (Figure  [3](#F3){ref-type="fig"}). These results indicate that the higher proportion of C16:1 and C18:1 may originate from *de novo* FA synthesis but not from the uptake of specific FAs from the medium.

![**Effect of DGAT2 overexpression on**^**13**^**C-labeled FA accumulation in adipocytes.** The cells were incubated with IFA-DM (DM containing 10 μmol/L ^13^C~16~-palmic acid, C~16~-palmitoleic acid, ^13^C~18~-stearic acid, ^13^C~18~-oleic acid, C~18~-linoleic acid, and C~20~-arachidic acid bound to 60 μmol/L FA-free BSA). After 12 d of differentiation, the mature adipocytes were collected for FA analysis by GC-IRMS. The results are expressed as the percentage of each FA (%). Data are presented as the mean ± SEM of six independent wells.](2049-1891-5-29-3){#F3}

Adipogenic gene expression in 3T3-L1 adipocytes overexpressing DGAT2
--------------------------------------------------------------------

As shown in Figures  [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}, mRNA and protein expression of adipose triglyceride lipase, acetyl CoA carboxylase (ACACA), FA synthase (FASN), stearoyl-CoA desaturase-1 (SCD1), and FA-binding protein (a-FABP) was significantly higher in 3T3-L1 adipocytes overexpressing DGAT2 than in control cells. In addition, mRNA expression of FA translocase (FAT/CD36) and peroxisomal proliferator-activated receptor γ (PPARγ) was higher in cells overexpressing DGAT2.

![**Effect of DGAT2 overexpression on adipogenic gene mRNA expression.** The cells were incubated with FA-DM (DM containing 10 μmol/L C~16~-palmic acid, C~16~-palmitoleic acid, C~18~-stearic acid, C~18~-oleic acid, C~18~-linoleic acid, and C~20~-arachidic acid bound to 60 μmol/L FA-free BSA). After 12 d of differentiation, total RNA in mature adipocytes were isolated for quantitative PCR. Adipocytes transfected with the empty pcDNA3.1(+) vectors were control cells. Results are presented as the mean ± SEM of six independent cell preparations. \**P* \< 0.05, \*\**P* \< 0.01.](2049-1891-5-29-4){#F4}

![**Effect of DGAT2 overexpression on adipogenic gene protein expression.** The cells were incubated with FA-DM (DM containing 10 μmol/L. C~16~-palmic acid, C~16~-palmitoleic acid, C~18~-stearic acid, C~18~-oleic acid, C~18~-linoleic acid, and C~20~-arachidic acid bound to 60 μmol/L FA-free BSA). After 12 d of differentiation, total protein in mature adipocytes was extracted for western blotting. **(A)** Western blotting images; **(B)** Statistical analysis of protein expression using Image J software. Cells transfected with the empty pcDNA3.1(+) vector were control cells. Results are presented as the mean ± SEM of three independent cell preparations. \**P* \< 0.05, \*\**P* \< 0.01.](2049-1891-5-29-5){#F5}

Discussion
==========

Previous studies have proved that DGAT2 plays an important role in lipid accumulation \[[@B17]\]. However, little is known about the influence of DGAT2 on the FA composition of adipocytes. Our study revealed that TAG accumulation, the proportion of MUFAs, and the expression of adipogenic genes were all higher in 3T3-L1 cells overexpressing DGAT2 than in control cells.

The existence of DGAT2 was first implicated from the finding that mice lacking DGAT1 had an abundance of TAG in their tissues \[[@B22]\]. Further research revealed that DGAT2 mRNA was highly expressed in several lipid metabolism tissues, including liver \[[@B23]\], mammary glands \[[@B24]\], and adipose tissue \[[@B25]\]. DGAT2 overexpression enhanced the accumulation of lipid droplets in COS-7 cells \[[@B17]\]. In contrast, DGAT2 knockdown decreased lipid storage in 3T3-L1 adipocytes \[[@B18]\]. Consistent with these studies, our results showed that the TAG content was significantly higher in 3T3-L1 adipocytes overexpressing DGAT2 than in control cells.

TAG formation is catalyzed by both DGAT1 and DGAT2, through the acylation of diacylglycerol \[[@B14],[@B15]\]. In mice, DGAT1 is known to have a strong substrate preference for incorporating oleoyl-CoA into TAG \[[@B15],[@B16]\]. Gene polymorphisms of DGAT in cows were reported to be closely related to the content of oleic acid in muscle \[[@B26]\]. Our results also demonstrated the novel function of porcine DGAT2 on the FA composition of adipocytes. When cultured in either DM or FA-DM for 12 d, 3T3-L1 adipocytes overexpressing DGAT2 showed a higher proportion of MUFAs (C16:1 and C18:1); when incubated in FA-DM for 30 min, the proportion of only palmitoleic acid (C16:1) was slightly elevated in cells overexpressing DGAT2 than in controls. However, when the cells were incubated with IFA-DM containing a stable IFA mixture, the proportion of ^13^C FAs was unchanged. These observations indicate that the long-term effects of DGAT2 overexpression in the FA profile may originate from *de novo* FA synthesis but not from the uptake of specific FAs from the culture medium.

To investigate the possible mechanism underlying the effects of DGAT2 on FA composition, we studied the expression of adipogenic genes in cells overexpressing DGAT2 mRNA and protein expression of ACACA, FASN, A-FABP, and SCD1 was significantly higher in 3T3-L1 adipocytes overexpressing DGAT2 than in control cells, as was the mRNA expression of FAT/CD36 and PPARγ. Of these genes, ACACA and FASN are the two key enzymes in *de novo* FA synthesis. This evidence suggests that the higher levels of lipid accumulation observed in cells overexpressing DGAT2 may result from *de novo* FA synthesis. Several studies have demonstrated that FAT/CD36, a-FABP, and SCD1 are associated with the uptake of MUFAs \[[@B11],[@B13],[@B27]\]. DGAT2 and SCD1 co-localize to a compartment involved in activating lipid synthesis, suggesting that SCD1 and DGAT2 play a coordinated role in TAG synthesis \[[@B28]\]. Thus, SCD1 may participate in TAG synthesis by producing an easily accessible pool of MUFA \[[@B29]\].

Although the function of DGAT2 has been described solely as the catalysis of TAG formation, we found that the expression of a great number of adipogenic genes was affected by DGAT2 overexpression. DAG, an important cellular second messenger, may be involved in this phenomenon. Considering that DGAT catalyzes TAG synthesis through DAG, numerous reports have shown that lower DGAT2 expression resulted in lower DAG content \[[@B30],[@B31]\], subsequently activating protein kinase Cϵ (PKCϵ) \[[@B32]-[@B35]\]. Therefore, we suspect that the expression of various adipogenic genes may be modulated by PKCϵ, which could increase the transcription of genes involved in FA biosynthesis by activating the sterol regulatory element binding protein 1c(SREBP1) \[[@B36]-[@B39]\]. The elucidation of the precise mechanism whereby DGAT2 affects adipogenic gene expression will require further study.

In conclusion, our study revealed that TAG accumulation, the cellular proportion of MUFAs, and the expression of adipogenic genes were higher in 3T3-L1 adipocytes overexpressing DGAT2 than in control cells. This information may be helpful in producing and selecting animals with a desirable FA profile.
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